TheJobsMapExalys Therapeutics jobs and careers
About Exalys Therapeutics
Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.
Founded in 2018 by BT Slingsby, Dennis Podlesak, Eckard Weber, Rick Orr and Takeshi Takahashi.
- Founded
- 2018
- Employees
- 11 to 50
- Total funding
- $15M
Leadership
The top of Exalys Therapeutics's org chart, with how many people report into each leader.
Rick Orr
CEO
4 reports
Shashidhar Kori
Chief Medical Officer
Lynne Rollins
Chief Financial Officer
William Martin
EVP, Corporate Development & Operations
Julien Mamet
Chief Scientific Officer
Board
David Yeomans
Advisor
Dennis Podlesak
Chairman
Colm Cunningham
Advisor
Eckard Weber
Director
William Schmidt
Advisor
BT Slingsby
Director
Jobs at Exalys Therapeutics
No open positions right now. Explore more companies on TheJobsMap.